31
Registered trials
13
Recruiting
11
Completed trials
27
Sponsors
18
Countries
Phase III:
5
Phase II/III:
2
Phase II:
18
Phase I/II:
3
Phase III/IV:
1
Phase IV:
1
Phase I (Other):
1
Oversight events:
3 temporary halts
1 urgent safety measure
2 unexpected events
1 corrective measure
across 4 trials
View oversight register →
Indications tested
Triple negative breast cancer
2
Head and neck cancer
2
Transitional cell carcinoma
2
Squamous cell carcinoma of head and neck
1
Anal cancer
1
Hepatocellular carcinoma
1
Penile cancer
1
Head and neck cancer metastatic
1
Oesophageal squamous cell carcinoma
1
Bladder cancer
1
Neuroendocrine carcinoma
1
Sponsors using this IMP
Bicycletx Limited
2
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
2
Groupe Oncologie Radiotherapie Tete Cou
2
Merck Healthcare KGaA
2
Centre Hospitalier Regional De Marseille
1
Centre Hospitalier Universitaire Rouen
1
Charite Universitaetsmedizin Berlin KöR
1
Fondation Franc.Cancerologie Digestive
1
Fondazione GONO Plus
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
1
Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
1
G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica
1
All trials — page 2
31 totalShowing 25–31 of 31 trials